Bullous pemphigoid (BP) is a rare chronic-relapsing autoimmune skin condition with fluid-filled blisters and other
inflammatory lesions. It is caused by the immune system attacking a layer of tissue in the skin. These outbreaks could be
triggered by certain medications. The reason why this happens is not fully understood.
While blisters may occur anywhere, they commonly form near creases in the skin.
Delay in diagnosis
leading to delayed
treatment
Severe itch
Painful sores in
affected areas
Signs and symptoms
persisting for months
to years if untreated
Finding a treatment to help signs and symptoms of BP is important. As the first and only FDA-approved treatment option for adults with BP, DUPIXENT targets a key source of underlying inflammation that may contribute to BP.
To help with recurring disease, it may be time to talk to a dermatologist.
Real patients living with BP.
Not actual DUPIXENT patients.